Sociedad Americana de Hirudoterapia

Salvage of fingertip amputated at nail level: new surgical principles and treatments

Research article published in Annals of plastic surgery (1997)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportEnsayos clínicosHirase · Annals of plastic surgery, 1997

Abstract

In this study, a new classification of fingertip amputation based on the surgical treatment is reported. Specifically, the necessity for special procedures to prevent venous congestion in fingertip replantation at the nail bed level was studied. There are some reports of successful replantations without venous anastomoses. In order to avoid technical factors, clinical cases operated on by a single surgeon were evaluated to determine what treatment is necessary for amputations at various levels to avoid necrosis due to venous congestion. During the 5-year period from October 1987 to October 1992, 150 replantations in 137 patients were performed, including 49 fingertip replantations in 45 patients who were operated on consecutively by a single surgeon. The distal phalanx (DP) of the finger was classified as zone DP-I, IIA, IIB, and III from distal to proximal. This classification was based not only on the amputation level but also on the difference in surgical treatment. For amputations of zone DP-I, which extends from the fingertip to the most distal dividing point of the digital artery, the amputated fingertip is attached without vascular anastomosis and the whole finger is wrapped in aluminium foil and cooled in ice water for 3 days. For amputations of zone DP-IIA and IIB, anastomosis of the digital artery is performed in the central portion of the palmar region of the finger, but Kirschner wire fixation is not performed so as not to disturb the venous drainage through the medullary cavity. For amputations of zone DP-IIA, special treatment is not necessary for venous congestion, and for those of zone DP-IIB partial resection of the nail is done if necessary. For zone DP-II amputations, venous anastomosis must be performed for salvage. All patients were operated on according to the procedures based on this classification and final survival rate was 91.5%.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAdultAmputation, TraumaticAnastomosis, SurgicalArteriesBone WiresFinger InjuriesFingersFollow-Up StudiesHumansInfantMaleMiddle Aged

Resumen

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Por qué esto importa para la hirudoterapia

Esta serie de casos de un solo cirujano, que comprende 49 reimplantaciones consecutivas de yema del dedo (dentro de 150 reimplantaciones durante cinco años), propuso una clasificación de zonas de la falange distal basada en el tratamiento quirúrgico y centrada en la prevención de la congestión venosa, reportando una tasa de supervivencia global del 91.5%, donde la zona más distal se manejó mediante la fijación de la yema del dedo sin anastomosis vascular y con enfriamiento, y las zonas más proximales requirieron anastomosis arterial o venosa. Este es uno de los registros más directamente pertinentes para la hirudoterapia, ya que la congestión venosa en la reimplantación distal, donde no se puede restaurar quirúrgicamente un flujo venoso adecuado, es la indicación clásica para la terapia con sanguijuelas medicinales con el fin de descomprimir el tejido congestionado. Advertencia honesta: se trata de una serie de casos de 1997 que describe la clasificación y técnica de un cirujano y no estudia ni cuantifica por sí misma la terapia con sanguijuelas; ilustra el problema clínico que las sanguijuelas abordan en lugar de proporcionar evidencia a nivel de ensayo clínico sobre las mismas.

Citación

Salvage of fingertip amputated at nail level: new surgical principles and treatments.

Hirase · Annals of plastic surgery, 1997

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.